BIAF Stock Plunges 77% in 3 Months: Should You Still Hold or Sell?
bioAffinity Technologies, Inc.’s BIAF investors have been experiencing some short-term losses. Shares of the San Antonio, TX-based biotechnology company have lost 77% in the past three months against the industry’s 4.5% rise. It has also underperformed the sector and the S&P 500’s gain of 8.2% and 10.1%, respectively, in the same time frame. Two major ...












